نتایج جستجو برای: idh

تعداد نتایج: 2014  

2015
Luyuan Li Ana C. Paz Breelyn A. Wilky Britt Johnson Karina Galoian Andrew Rosenberg Guozhi Hu Gabriel Tinoco Olaf Bodamer Jonathan C. Trent Ken Mills

Chondrosarcomas are malignant bone tumors that produce cartilaginous matrix. Mutations in isocitrate dehydrogenase enzymes (IDH1/2) were recently described in several cancers including chondrosarcomas. The IDH1 inhibitor AGI-5198 abrogates the ability of mutant IDH1 to produce the oncometabolite D-2 hydroxyglutarate (D-2HG) in gliomas. We sought to determine if treatment with AGI-5198 would sim...

2017
Yujin Lee Jaemoon Koh Seong-Ik Kim Jae Kyung Won Chul-Kee Park Seung Hong Choi Sung-Hye Park

Mutations in the telomerase reverse transcriptase gene promoter (TERTp) are common in glioblastomas (GBMs) and oligodendrogliomas (ODGs), and therefore, have a key role in tumorigenesis and may be of prognostic value. However, the extent of their prognostic importance in various gliomas is controversial. We studied 168 patients separated into five groups: Group 1: 65 patients with ODG carrying ...

2012
Sadudee Chotirat Wanna Thongnoppakhun Orathai Promsuwicha Chetsada Boonthimat Chirayu U Auewarakul

BACKGROUND Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes encode cytosolic and mitochondrial enzymes that catalyze the conversion of isocitrate to α-ketoglutarate. Acquired somatic mutations of IDH1 and IDH2 have recently been reported in some types of brain tumors and a small proportion of acute myeloid leukemia (AML) cases. METHODS Two-hundred and thirty newly diagnosed AM...

Journal: :Clinical Lymphoma Myeloma and Leukemia 2020

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Hiroaki Wakimoto Shota Tanaka William T Curry Franziska Loebel Dan Zhao Kensuke Tateishi Juxiang Chen Lindsay K Klofas Nina Lelic James C Kim Dora Dias-Santagata Leif W Ellisen Darrell R Borger Sarah-Maria Fendt Matthew G Vander Heiden Tracy T Batchelor A John Iafrate Daniel P Cahill Andrew S Chi

PURPOSE Isocitrate dehydrogenase (IDH) gene mutations occur in low-grade and high-grade gliomas. We sought to identify the genetic basis of malignant phenotype heterogeneity in IDH-mutant gliomas. METHODS We prospectively implanted tumor specimens from 20 consecutive IDH1-mutant glioma resections into mouse brains and genotyped all resection specimens using a CLIA-certified molecular panel. G...

2016
Gemma L. Robinson Beatrice Philip Matthew R. Guthrie James E. Cox James P. Robinson Matthew W. VanBrocklin Sheri L. Holmen

Mutations in the metabolic enzyme isocitrate dehydrogenase (IDH) were recently found in ~80% of WHO grade II-III gliomas and secondary glioblastomas. These mutations reduce the enzyme's ability to convert isocitrate to α-ketoglutarate and, instead, confer a novel gain-of-function resulting in the conversion of α-ketoglutarate to 2-hydroxglutarate (2-HG). However, IDH mutations exist in a hetero...

Journal: :Medical engineering & physics 2015
D Hernando L Sörnmo F Sandberg P Laguna M Llamedo R Bailón

Intradialytic hypotension (IDH) is a major complication during hemodialysis treatment, and therefore it is highly desirable to identify, at an early stage during treatment, whether the patient is prone to IDH. Heart rate variability (HRV), blood pressure variability (BPV) and baroreflex sensitivity (BRS) were analyzed during the first 30 min of treatment to assess information on the autonomic n...

2018
Dan Ye Kun-Liang Guan Yue Xiong

Isocitrate dehydrogenases (IDH1/2) are frequently mutated in multiple types of human cancer, resulting in neomorphic enzymes that convert α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG). The current view on the mechanism of IDH mutation holds that 2-HG acts as an antagonist of α-KG to competitively inhibit the activity of α-KG-dependent dioxygenases, including those involved in histone and ...

Journal: :Trends in ecology & evolution 2013
Jeremy W Fox

A leading idea about how disturbances and other environmental fluctuations affect species diversity is the intermediate disturbance hypothesis (IDH). The IDH states that diversity of competing species is, or should be expected to be, maximized at intermediate frequencies and/or intensities of disturbance or environmental change. I argue that the IDH has been refuted on both empirical and theore...

2017
Yonal-Hindilerden Ipek Daglar-Aday Aynur Hindilerden Fehmi Nalcaci Meliha Yavuz Akif Selim Sargin Deniz

Iran J Med Sci March 2017; Vol 42 No 2 219 Dear Editor, Philadelphia-negative myeloproliferative neoplasms (MPNs) were first described 65 years ago. Yet, the molecular features of the disease have become of interest since 2005 following the identification of the JAK2V617F mutation.1 Between 90% and 98% of patients with polycythemia vera and about 50% of patients with essential thrombocythemia (...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید